These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 14156122)

  • 21. [Influence of trypsin on the fibrinolytic system of normal serum treated with plasmin or streptokinase].
    GIACOMAZZI G
    Haematologica; 1962; 47():875-906. PubMed ID: 13947574
    [No Abstract]   [Full Text] [Related]  

  • 22. [Action of elastase on fibrinolysis activated with streptokinase. Thromboelastographic research].
    FICHERA C; FERRAUTO A
    Boll Soc Ital Biol Sper; 1961 Dec; 37():1177-8. PubMed ID: 13892720
    [No Abstract]   [Full Text] [Related]  

  • 23. FIBRINOLYSIS.
    ADAMIS D
    Conn Med; 1964 Sep; 28():662-7. PubMed ID: 14201318
    [No Abstract]   [Full Text] [Related]  

  • 24. Safety of intravenous proteolytic enzymes (varizyme) in equine practice.
    BRAYE ET; HINSMAN EJ; RILEY WF
    J Am Vet Med Assoc; 1960 Jan; 136():73-4. PubMed ID: 13804059
    [No Abstract]   [Full Text] [Related]  

  • 25. THE USE OF UROKINASE IN THE ANTERIOR CHAMBER OF THE EYE.
    PIERSE D; LEGRICE H
    J Clin Pathol; 1964 May; 17(3):362. PubMed ID: 14159484
    [No Abstract]   [Full Text] [Related]  

  • 26. ACTION OF THE NEW ANTI-FIBRINOLYTIC SUBSTANCE ON THE STREPTOKINASE-ACTIVATED PROTEASES (PLASMINS).
    MIHARA H
    Kobe J Med Sci; 1963 Dec; 18():169-77. PubMed ID: 14160537
    [No Abstract]   [Full Text] [Related]  

  • 27. THE INTERACTION OF STREPTOKINASE WITH PLASMINOGEN. I. FUNCTIONAL PROPERTIES OF THE ACTIVATED ENZYME.
    MARKUS G; WERKHEISER WC
    J Biol Chem; 1964 Aug; 239():2637-43. PubMed ID: 14235547
    [No Abstract]   [Full Text] [Related]  

  • 28. THROMBOLYTIC THERAPY.
    MCNICOL GP; DOUGLAS AS
    J Clin Pathol; 1964 May; 17(3):338-40. PubMed ID: 14159477
    [No Abstract]   [Full Text] [Related]  

  • 29. PEPTIDASE ACTIVITY IN RAT URINE FOLLOWING ORALLY GIVEN PROTEASES.
    INNERFIELD I; GIMBLE FS; BLINCOE E
    Life Sci (1962); 1963 Sep; 9():671-5. PubMed ID: 14068039
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies on the activating factors in fibrinolytic system. II. Streptococcal and staphylococcal fibrinolysis.
    HAYASHI T; MAEKAWA S
    Jpn J Exp Med; 1954 Oct; 24(5):287-305. PubMed ID: 13242259
    [No Abstract]   [Full Text] [Related]  

  • 31. SOME CONSIDERATIONS IN THE SYSTEMIC USE OF FIBRINOLYTIC AGENT.
    COON WW
    Mich Med; 1964 Jul; 63():488-90. PubMed ID: 14182774
    [No Abstract]   [Full Text] [Related]  

  • 32. [THERAPY OF THROMBOEMBOLISM AND FIBRINOLYSIS].
    SANTOSTORIBIO F
    Prog Ter Clin; 1963 Oct; 17():9-18. PubMed ID: 14097889
    [No Abstract]   [Full Text] [Related]  

  • 33. [TRYPSIN-CHYMOTRYPSIN IN THE VASCULAR OCCLUSIVE PROCESSES].
    MOSSO HE; PERGOLA F; MARCEILLAC E
    Prensa Med Argent; 1963 Apr; 50():1081-4. PubMed ID: 14089189
    [No Abstract]   [Full Text] [Related]  

  • 34. The activation of human plasminogen. II. A kinetic study of activation with trypsin, urokinase, and streptokinase.
    ALKJAERSIG N; FLETCHER AP; SHERRY S
    J Biol Chem; 1958 Jul; 233(1):86-90. PubMed ID: 13563446
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibition of plasmin, trypsin and the streptokinase-activated fibrinolytic system by 6-aminocaproic acid.
    ABLONDI FB; HAGAN JJ; PHILIPS M; DE RENZO EC
    Arch Biochem Biophys; 1959 May; 82(1):153-60. PubMed ID: 13650650
    [No Abstract]   [Full Text] [Related]  

  • 36. Standardization of fibrinolytic preparations. Measurement of proteolytic and activator activity of streptokinase-activated human plasminogen.
    BAUMGARTEN W; CIMINERA JL; VAN PELT SM
    J Pharm Sci; 1962 Apr; 51():314-7. PubMed ID: 13865955
    [No Abstract]   [Full Text] [Related]  

  • 37. CURRENT STATUS OF THROMBOLYTIC THERAPY.
    SHERRY S
    Geriatrics; 1964 Sep; 19():628-43. PubMed ID: 14221883
    [No Abstract]   [Full Text] [Related]  

  • 38. FIBRINOLYTIC AGENTS IN TREATMENT OF TOTAL HYPHEMA AND SECONDARY GLAUCOMA.
    ROBERTS RA
    Tex State J Med; 1965 Mar; 61():181-3. PubMed ID: 14266135
    [No Abstract]   [Full Text] [Related]  

  • 39. Proteolytic and fibrinolytic activity of serum; activation by streptokinase and staphylokinase indicating dissimilarity of enzymes.
    CLIFFTON EE; CANNAMELA DA
    Blood; 1953 Jun; 8(6):554-62. PubMed ID: 13059041
    [No Abstract]   [Full Text] [Related]  

  • 40. Preliminary study of use of buccal protease therapy in bronchial asthma.
    FRANKEL DB; AARONSON AB; EHRLICH NJ
    Ann Allergy; 1959; 17():883-6. PubMed ID: 13824547
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.